<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: There is growing evidence describing DNA repair genes polymorphisms are related to increased <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk including <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to investigate the associations between the APE1 Asp148Glu, hOGG1 Ser326Cys, XRCC1 Arg399Gln, XRCC3 Thr241Met, <z:e sem="disease" ids="C0268138" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">XPD</z:e> Lys751Gln, <z:e sem="disease" ids="C0268141" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="XP7">XPG</z:e> Asp1104His polymorphisms and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk in Turkish population </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: Polymorphisms of APE1 Asp148Glu (rs3136820), hOGG1 Ser326Cys (rs1052133), XRCC1 Arg399Gln(rs25487), XRCC3 Thr241Met (rs861539), <z:e sem="disease" ids="C0268138" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">XPD</z:e> Lys751Gln (rs13181), and <z:e sem="disease" ids="C0268141" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="XP7">XPG</z:e> Asp1104His (rs17655) were determined by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) methods in blood samples of 79 CRC patients at their initial staging and 247 healthy controls </plain></SENT>
<SENT sid="3" pm="."><plain>Of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients, 26 out of 40 were diagnosed with <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> and received neoadjuvant chemoradiotherapy following diagnosis; 39 others were diagnosed as <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Our preliminary results showed that frequencies of Glu allele of APE1 Asp148Glu and Cys allele of hOGG1 Ser326Cys were higher in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients than in controls (p = 0.006, OR: 3.43; 95% CI: 1.76-6.70; p = 0.000, OR: 2.77; 95% CI: 1.40-5.48, respectively) </plain></SENT>
<SENT sid="5" pm="."><plain>Higher frequency of Met allele of XRCC3 Thr241Met was detected in patients treated with neoadjuvant chemoradiotherapy (p = 0.024, OR: 5.25; 95% CI: 1.23-23.39) and with proximal <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumors</z:e> (p = 0.04, OR: 2; 95% CI: 1.18-3.34) </plain></SENT>
<SENT sid="6" pm="."><plain>Increased frequency of Ser/Ser genotype of hOGG1 Ser326Cys was found to be associated both with higher grade (p = 0.001, OR: 6.4; 95% CI: 2.69-62.69) and <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> (p = 0.005, OR: 7.5; 95% CI: 0.7-68.36) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: APE1 Asp148Glu and hOGG1 Ser326Cys polymorphisms might be associated with increasing risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in a Turkish population </plain></SENT>
<SENT sid="8" pm="."><plain>Future studies with larger-sized samples, as well as detecting the association of DNA repair genes with other confounding factors will help elucidate the exact roles of DNA repair genes polymorphisms in development and progression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>